The purpose of this research study is to better understand the immune response to the
Adjuvanted Subunit flu vaccine (MF59) and the High Dose flu vaccine (HDFlu) in people 65
years of age and older. The research team will be studying why immune response diminishes as
people get older in both men and women. The ultimate goal is to understand how flu immunity
develops after vaccination. This information may lead to the development of more effective
flu vaccines in the future.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)